Skip to content

AYURVEDIC MANAGEMENT OF KAPHAJA YONIVYAPAD

CLINICAL EFFECT OF HARIDRADI YONI DHOOPAN ON KAPHAJA YONIVYAPAD - CEOHYDOKY

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/10/037666
Enrollment
30
Registered
2021-10-28
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N738- Other specified female pelvic inflammatory diseases

Interventions

Intervention1: YONI DHOOPAN (by Dhoopan Varti, prepared according to Dhoopan Yantra): TWICE DAILY FOR 7DAYS (AFTER CESSATION OF MENSES, FOR TWO CONSECUTIVE CYCLE) Control Intervention1: NIL: NIL

Sponsors

UNIVERSITY COLLEGE OF AYURVEDA JODHPUR
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: MARRIED WOMAN AGED BETWEEN 18 YEARS TO MENOPAUSE THE PATIENTS HAVING KAPHAJA YONIVYAPADA i.e. HAVING FOLLOWING SIGN AND SYMPTOMS YONI KANDU ALPA VEDANA YONI SRAVA

Exclusion criteria

Exclusion criteria: UNMARRIED WOMAN AGE BELOW 18 YEARS AND AFTER MENOPAUSE (THOSE WHO ARE MENSTRUATING WOMEN) PREGNANT WOMEN AND LACTATING WOMEN PATIENTS SUFFEREING FROM TUBERCULOSIS SEXUALLY TRANSMITTED DISEASE LIKE VDRL HIV GONORRHOEA GENITAL MALIGNANCY CONGENITAL ANOMALIES ANY OTHER PATHOLOGIES OF REPRODUCTIVE TRACT CERVICAL POLYP FIBROIDS SENILE VAGINITIS

Design outcomes

Primary

MeasureTime frame
Improvement in cardinal and associated clinical features related to Kaphaja YonivyapadTimepoint: Improvement in cardinal and associated clinical features related to Kaphaja Yonivyapad after 7days of Yoni Dhoopan application

Secondary

MeasureTime frame
Improvement in cardinal and associated clinical features related to Kaphaja YonivyapadTimepoint: 60days

Countries

India

Contacts

Public ContactDr A Neelima

UCA, DSRRAU, JODHPUR.

aspneelima@gmail.com9610350131

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026